Table 2.
ASD (M ± SD) | TD (M ± SD) | Unadjusted p-Value | Adjusted p-Value | |
---|---|---|---|---|
Time in Bed (min) | 593.1 (65.2) | 505.4 (70.3) | <0.0005 | 0.001 |
Total Sleep Time (min) | 508.3 (59.8) | 471.7 (68) | 0.07 | 0.30 |
Sleep Onset Latency (min) | 34.1 (23.1) | 12.8 (9.9) | <0.0005 | 0.002 |
Wake After Sleep Onset (min) | 50.7 (39.6) | 20.9 (13.1) | 0.002 | 0.003 |
Sleep Efficiency (%) | 86.2 (6.6) | 93.3 (2.2) | <0.0005 | <0.0005 |
Number of wakings | 12.7 (10.9) | 6.6 (5.1) | 0.02 | 0.08 |
N1% | 3.8 (2.5) | 3.0 (1.7) | 0.24 | 0.25 |
N2% | 47.1 (10.2) | 45.1 (7.7) | 0.46 | 0.92 |
N3% | 29.1 (8.2) | 29.1 (6.2) | 0.99 | 0.32 |
REM (%) | 20.0 (6.6) | 22.7 (4.2) | 0.11 | 0.07 |
REM latency (min) | 142.7 (69.7) | 115.3 (39.6) | 0.11 | 0.13 |
Frontal REM theta power (µV2/Hz−1) | 18.6 (9) | 19.1 (8.2) | 0.90 | 0.86 |
REM beta (µV2/Hz−1) | 3.3 (1.6) | 3.9 (1.3) | 0.34 | 0.23 |
Global NREM SWA power (µV2/Hz−1) | 283.01 (164.5) | 216.41 (124.0) | 0.16 | 0.21 |
Adjusted p-value reflects inclusion of standard NVIQ and any medication variables in linear regression model. Bolded p-values represent significance p < 0.05.